0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amifostine Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-1278
Home | Category |Health |Health Conditions |Cancer
Global Amifostine Market Insights Forecast to 2025

Global Amifostine Market Insights, Forecast to 2025

Code: QYRE-Auto-1278
Report
May 2019
112 Pages
QYResearch
Region: Global, Asia Pacific, North America,
Description
Table of Content
Tables & Figures
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.
Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells. Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share. The market is relatively concentrated and there are just a few suppliers in the market, such as Clinigen Group, Sun Pharmaceutical, Merro Pharmaceutical and so on. Clinigen Group acquired the business from AstraZeneca in the year of 2014 and signed an agreement with Cumberland in the year of 2016. Under the agreement, Cumberland acquired the exclusive rights to commercialize Ethyol in the United States. Merro Pharmaceutical own the largest sales share in China. Amifostine shows good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment. It is estimated that the amifostine market will keep upward tendency and to be worthy of 49.99 million USD in 2023 globally.
The global Amifostine market is valued at 48 million US$ in 2018 and will reach 57 million US$ by the end of 2025, growing at a CAGR of 2.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Amifostine market based on company, product type, end user and key regions.

This report studies the global market size of Amifostine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Amifostine in these regions.
This research report categorizes the global Amifostine market by top players/brands, region, type and end user. This report also studies the global Amifostine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Clinigen Group
    Sun Pharmaceutical
    Taj Pharmaceuticals
    Merro Pharmaceutical
    Luye Pharma
    Mingren Pharma

Market size by Product
    400mg/Dose
    500mg/Dose
Market size by End User
    Head and Neck Cancer Adjuvant Therapy
    Others

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Amifostine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Amifostine market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Amifostine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Amifostine submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Amifostine are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Amifostine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Amifostine Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Amifostine Market Size Growth Rate by Product
        1.4.2 400mg/Dose
        1.4.3 500mg/Dose
    1.5 Market by End User
        1.5.1 Global Amifostine Market Size Growth Rate by End User
        1.5.2 Head and Neck Cancer Adjuvant Therapy
        1.5.3 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Amifostine Market Size
        2.1.1 Global Amifostine Revenue 2014-2025
        2.1.2 Global Amifostine Sales 2014-2025
    2.2 Amifostine Growth Rate by Regions
        2.2.1 Global Amifostine Sales by Regions
        2.2.2 Global Amifostine Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Amifostine Sales by Manufacturers
        3.1.1 Amifostine Sales by Manufacturers
        3.1.2 Amifostine Sales Market Share by Manufacturers
        3.1.3 Global Amifostine Market Concentration Ratio (CR5 and HHI)
    3.2 Amifostine Revenue by Manufacturers
        3.2.1 Amifostine Revenue by Manufacturers (2014-2019)
        3.2.2 Amifostine Revenue Share by Manufacturers (2014-2019)
    3.3 Amifostine Price by Manufacturers
    3.4 Amifostine Manufacturing Base Distribution, Product Types
        3.4.1 Amifostine Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Amifostine Product Type
        3.4.3 Date of International Manufacturers Enter into Amifostine Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Amifostine Sales by Product
    4.2 Global Amifostine Revenue by Product
    4.3 Amifostine Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Amifostine Breakdown Data by End User

6 North America
    6.1 North America Amifostine by Countries
        6.1.1 North America Amifostine Sales by Countries
        6.1.2 North America Amifostine Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Amifostine by Product
    6.3 North America Amifostine by End User

7 Europe
    7.1 Europe Amifostine by Countries
        7.1.1 Europe Amifostine Sales by Countries
        7.1.2 Europe Amifostine Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Amifostine by Product
    7.3 Europe Amifostine by End User

8 Asia Pacific
    8.1 Asia Pacific Amifostine by Countries
        8.1.1 Asia Pacific Amifostine Sales by Countries
        8.1.2 Asia Pacific Amifostine Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Amifostine by Product
    8.3 Asia Pacific Amifostine by End User

9 Central & South America
    9.1 Central & South America Amifostine by Countries
        9.1.1 Central & South America Amifostine Sales by Countries
        9.1.2 Central & South America Amifostine Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Amifostine by Product
    9.3 Central & South America Amifostine by End User

10 Middle East and Africa
    10.1 Middle East and Africa Amifostine by Countries
        10.1.1 Middle East and Africa Amifostine Sales by Countries
        10.1.2 Middle East and Africa Amifostine Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Amifostine by Product
    10.3 Middle East and Africa Amifostine by End User

11 Company Profiles
    11.1 Clinigen Group
        11.1.1 Clinigen Group Company Details
        11.1.2 Company Business Overview
        11.1.3 Clinigen Group Amifostine Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Clinigen Group Amifostine Products Offered
        11.1.5 Clinigen Group Recent Development
    11.2 Sun Pharmaceutical
        11.2.1 Sun Pharmaceutical Company Details
        11.2.2 Company Business Overview
        11.2.3 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Sun Pharmaceutical Amifostine Products Offered
        11.2.5 Sun Pharmaceutical Recent Development
    11.3 Taj Pharmaceuticals
        11.3.1 Taj Pharmaceuticals Company Details
        11.3.2 Company Business Overview
        11.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Taj Pharmaceuticals Amifostine Products Offered
        11.3.5 Taj Pharmaceuticals Recent Development
    11.4 Merro Pharmaceutical
        11.4.1 Merro Pharmaceutical Company Details
        11.4.2 Company Business Overview
        11.4.3 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Merro Pharmaceutical Amifostine Products Offered
        11.4.5 Merro Pharmaceutical Recent Development
    11.5 Luye Pharma
        11.5.1 Luye Pharma Company Details
        11.5.2 Company Business Overview
        11.5.3 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Luye Pharma Amifostine Products Offered
        11.5.5 Luye Pharma Recent Development
    11.6 Mingren Pharma
        11.6.1 Mingren Pharma Company Details
        11.6.2 Company Business Overview
        11.6.3 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Mingren Pharma Amifostine Products Offered
        11.6.5 Mingren Pharma Recent Development

12 Future Forecast
    12.1 Amifostine Market Forecast by Regions
        12.1.1 Global Amifostine Sales Forecast by Regions 2019-2025
        12.1.2 Global Amifostine Revenue Forecast by Regions 2019-2025
    12.2 Amifostine Market Forecast by Product
        12.2.1 Global Amifostine Sales Forecast by Product 2019-2025
        12.2.2 Global Amifostine Revenue Forecast by Product 2019-2025
    12.3 Amifostine Market Forecast by End User
    12.4 North America Amifostine Forecast
    12.5 Europe Amifostine Forecast
    12.6 Asia Pacific Amifostine Forecast
    12.7 Central & South America Amifostine Forecast
    12.8 Middle East and Africa Amifostine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Amifostine Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Amifostine Product Picture
    Table Amifostine Market Segments
    Table Key Manufacturers Amifostine Covered
    Table Global Amifostine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
    Figure Global Amifostine Sales Market Share by Product 2014-2025
    Figure 400mg/Dose Product Picture
    Table Major Manufacturers of 400mg/Dose
    Figure 500mg/Dose Product Picture
    Table Major Manufacturers of 500mg/Dose
    Table Global Amifostine Market Size Growth Rate by End User 2019-2025 (K Units)
    Figure Head and Neck Cancer Adjuvant Therapy
    Figure Others
    Figure Amifostine Report Years Considered
    Figure Global Amifostine Market Size 2014-2025 (Million US$)
    Figure Global Amifostine Sales 2014-2025 (K Units)
    Table Global Amifostine Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Amifostine Sales by Regions 2014-2019 (K Units)
    Table Global Amifostine Sales Market Share by Regions 2014-2019
    Figure Global Amifostine Sales Market Share by Regions 2014-2019
    Figure 2018 Global Amifostine Sales Market Share by Regions
    Table Global Amifostine Revenue by Regions 2014-2019 (Million US$)
    Table Global Amifostine Revenue Market Share by Regions 2014-2019
    Figure Global Amifostine Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Amifostine Revenue Market Share by Regions
    Table Global Amifostine Sales by Manufacturers (2014-2019) (K Units)
    Table Global Amifostine Sales Share by Manufacturers (2014-2019)
    Figure Global Amifostine Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Amifostine Revenue by Manufacturers (2014-2019) (Million USD)
    Table Amifostine Revenue Share by Manufacturers (2014-2019)
    Figure Amifostine Value Share by Manufacturers in 2018
    Table Key Manufacturers Amifostine Price (2014-2019) (USD/Unit)
    Table Amifostine Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Amifostine Product Type
    Table Date of International Manufacturers Enter into Amifostine Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Amifostine Sales by Product (2014-2019) (K Units)
    Table Global Amifostine Sales Share by Product (2014-2019)
    Figure Global Amifostine Sales Market Share by Product (2014-2019)
    Figure Global Amifostine Sales Market Share by Product in 2018
    Table Global Amifostine Revenue by Product (2014-2019) (Million US$)
    Table Global Amifostine Revenue Share by Product (2014-2019)
    Figure Global Amifostine Revenue Market Share by Product (2014-2019)
    Figure Global Amifostine Revenue Market Share by Product in 2018
    Table Amifostine Price by Product 2014-2019 (USD/Unit)
    Table Global Amifostine Sales by End User (2014-2019) (K Units)
    Table Global Amifostine Sales Share by End User (2014-2019)
    Figure Global Sales Amifostine Market Share by End User (2014-2019)
    Figure Global Sales Amifostine Market Share by End User in 2018
    Figure North America Amifostine Sales Growth Rate 2014-2019 (K Units)
    Figure North America Amifostine Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Amifostine Sales by Countries (2014-2019) (K Units)
    Table North America Amifostine Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Amifostine Sales Market Share by Countries
    Table North America Amifostine Revenue by Countries (2014-2019) (Million US$)
    Table North America Amifostine Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Amifostine Revenue Market Share by Countries
    Figure United States Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure United States Amifostine Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Amifostine Sales by Product (2014-2019) (K Units)
    Table North America Amifostine Sales Market Share by Product (2014-2019)
    Figure 2018 North America Amifostine Market Share by Product
    Table North America Amifostine Sales by End User (2014-2019) (K Units)
    Table North America Amifostine Sales Market Share by End User (2014-2019)
    Figure 2018 North America Amifostine Market Share by End User
    Figure Europe Amifostine Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Amifostine Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Amifostine Sales by Countries (2014-2019) (K Units)
    Table Europe Amifostine Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Amifostine Sales Market Share by Countries
    Table Europe Amifostine Revenue by Countries (2014-2019) (Million US$)
    Table Europe Amifostine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Amifostine Revenue Market Share by Countries
    Figure Germany Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure France Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure UK Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Amifostine Sales by Product (2014-2019) (K Units)
    Table Europe Amifostine Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Amifostine Market Share by Product
    Table Europe Amifostine Sales by End User (2014-2019) (K Units)
    Table Europe Amifostine Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Amifostine Market Share by End User
    Figure Asia Pacific Amifostine Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Amifostine Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Amifostine Sales by Countries (2014-2019) (K Units)
    Table Asia Pacific Amifostine Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Amifostine Sales Market Share by Countries
    Table Asia Pacific Amifostine Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Amifostine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Amifostine Revenue Market Share by Countries
    Figure China Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure China Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure India Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Amifostine Sales by Product (2014-2019) (K Units)
    Table Asia Pacific Amifostine Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Amifostine Market Share by Product
    Table Asia Pacific Amifostine Sales by End User (2014-2019) (K Units)
    Table Asia Pacific Amifostine Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Amifostine Market Share by End User
    Figure Central & South America Amifostine Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Amifostine Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Amifostine Sales by Countries (2014-2019) (K Units)
    Table Central & South America Amifostine Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Amifostine Sales Market Share by Countries
    Table Central & South America Amifostine Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Amifostine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Amifostine Revenue Market Share by Countries
    Figure Brazil Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Amifostine Sales by Product (2014-2019) (K Units)
    Table Central & South America Amifostine Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Amifostine Market Share by Product
    Table Central & South America Amifostine Sales by End User (2014-2019) (K Units)
    Table Central & South America Amifostine Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Amifostine Market Share by End User
    Figure Middle East and Africa Amifostine Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Amifostine Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Amifostine Sales by Countries (2014-2019) (K Units)
    Table Middle East and Africa Amifostine Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Amifostine Sales Market Share by Countries
    Table Middle East and Africa Amifostine Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Amifostine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Amifostine Revenue Market Share by Countries
    Figure GCC Countries Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Amifostine Sales by Product (2014-2019) (K Units)
    Table Middle East and Africa Amifostine Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Amifostine Market Share by Product
    Table Middle East and Africa Amifostine Sales by End User (2014-2019) (K Units)
    Table Middle East and Africa Amifostine Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Amifostine Market Share by End User
    Table Clinigen Group Company Details
    Table Clinigen Group Amifostine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Clinigen Group Recent Development
    Table Sun Pharmaceutical Company Details
    Table Sun Pharmaceutical Amifostine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Sun Pharmaceutical Recent Development
    Table Taj Pharmaceuticals Company Details
    Table Taj Pharmaceuticals Amifostine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Taj Pharmaceuticals Recent Development
    Table Merro Pharmaceutical Company Details
    Table Merro Pharmaceutical Amifostine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Merro Pharmaceutical Recent Development
    Table Luye Pharma Company Details
    Table Luye Pharma Amifostine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Luye Pharma Recent Development
    Table Mingren Pharma Company Details
    Table Mingren Pharma Amifostine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Mingren Pharma Recent Development
    Table Global Amifostine Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Amifostine Sales Market Share Forecast by Regions 2019-2025
    Table Global Amifostine Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Amifostine Revenue Market Share Forecast by Regions 2019-2025
    Table Global Amifostine Sales Forecast by Product 2019-2025 (K Units)
    Table Global Amifostine Sales Market Share Forecast by Product 2019-2025
    Table Global Amifostine Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Amifostine Revenue Market Share Forecast by Product 2019-2025
    Table Global Amifostine Sales Forecast by End User 2019-2025 (K Units)
    Table Global Amifostine Sales Market Share Forecast by End User 2019-2025
    Figure North America Amifostine Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Amifostine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Amifostine Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Amifostine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Amifostine Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Amifostine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Amifostine Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Amifostine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Amifostine Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Amifostine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Amifostine Value Chain
    Table Amifostine Customers List
    Table Amifostine Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.
Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells. Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share. The market is relatively concentrated and there are just a few suppliers in the market, such as Clinigen Group, Sun Pharmaceutical, Merro Pharmaceutical and so on. Clinigen Group acquired the business from AstraZeneca in the year of 2014 and signed an agreement with Cumberland in the year of 2016. Under the agreement, Cumberland acquired the exclusive rights to commercialize Ethyol in the United States. Merro Pharmaceutical own the largest sales share in China. Amifostine shows good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment. It is estimated that the amifostine market will keep upward tendency and to be worthy of 49.99 million USD in 2023 globally.
The global Amifostine market is valued at 48 million US$ in 2018 and will reach 57 million US$ by the end of 2025, growing at a CAGR of 2.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Amifostine market based on company, product type, end user and key regions.

This report studies the global market size of Amifostine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Amifostine in these regions.
This research report categorizes the global Amifostine market by top players/brands, region, type and end user. This report also studies the global Amifostine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Clinigen Group
    Sun Pharmaceutical
    Taj Pharmaceuticals
    Merro Pharmaceutical
    Luye Pharma
    Mingren Pharma

Market size by Product
    400mg/Dose
    500mg/Dose
Market size by End User
    Head and Neck Cancer Adjuvant Therapy
    Others

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Amifostine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Amifostine market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Amifostine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Amifostine submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Amifostine are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Amifostine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Read More
Table of Contents

1 Study Coverage
    1.1 Amifostine Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Amifostine Market Size Growth Rate by Product
        1.4.2 400mg/Dose
        1.4.3 500mg/Dose
    1.5 Market by End User
        1.5.1 Global Amifostine Market Size Growth Rate by End User
        1.5.2 Head and Neck Cancer Adjuvant Therapy
        1.5.3 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Amifostine Market Size
        2.1.1 Global Amifostine Revenue 2014-2025
        2.1.2 Global Amifostine Sales 2014-2025
    2.2 Amifostine Growth Rate by Regions
        2.2.1 Global Amifostine Sales by Regions
        2.2.2 Global Amifostine Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Amifostine Sales by Manufacturers
        3.1.1 Amifostine Sales by Manufacturers
        3.1.2 Amifostine Sales Market Share by Manufacturers
        3.1.3 Global Amifostine Market Concentration Ratio (CR5 and HHI)
    3.2 Amifostine Revenue by Manufacturers
        3.2.1 Amifostine Revenue by Manufacturers (2014-2019)
        3.2.2 Amifostine Revenue Share by Manufacturers (2014-2019)
    3.3 Amifostine Price by Manufacturers
    3.4 Amifostine Manufacturing Base Distribution, Product Types
        3.4.1 Amifostine Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Amifostine Product Type
        3.4.3 Date of International Manufacturers Enter into Amifostine Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Amifostine Sales by Product
    4.2 Global Amifostine Revenue by Product
    4.3 Amifostine Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Amifostine Breakdown Data by End User

6 North America
    6.1 North America Amifostine by Countries
        6.1.1 North America Amifostine Sales by Countries
        6.1.2 North America Amifostine Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Amifostine by Product
    6.3 North America Amifostine by End User

7 Europe
    7.1 Europe Amifostine by Countries
        7.1.1 Europe Amifostine Sales by Countries
        7.1.2 Europe Amifostine Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Amifostine by Product
    7.3 Europe Amifostine by End User

8 Asia Pacific
    8.1 Asia Pacific Amifostine by Countries
        8.1.1 Asia Pacific Amifostine Sales by Countries
        8.1.2 Asia Pacific Amifostine Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Amifostine by Product
    8.3 Asia Pacific Amifostine by End User

9 Central & South America
    9.1 Central & South America Amifostine by Countries
        9.1.1 Central & South America Amifostine Sales by Countries
        9.1.2 Central & South America Amifostine Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Amifostine by Product
    9.3 Central & South America Amifostine by End User

10 Middle East and Africa
    10.1 Middle East and Africa Amifostine by Countries
        10.1.1 Middle East and Africa Amifostine Sales by Countries
        10.1.2 Middle East and Africa Amifostine Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Amifostine by Product
    10.3 Middle East and Africa Amifostine by End User

11 Company Profiles
    11.1 Clinigen Group
        11.1.1 Clinigen Group Company Details
        11.1.2 Company Business Overview
        11.1.3 Clinigen Group Amifostine Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Clinigen Group Amifostine Products Offered
        11.1.5 Clinigen Group Recent Development
    11.2 Sun Pharmaceutical
        11.2.1 Sun Pharmaceutical Company Details
        11.2.2 Company Business Overview
        11.2.3 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Sun Pharmaceutical Amifostine Products Offered
        11.2.5 Sun Pharmaceutical Recent Development
    11.3 Taj Pharmaceuticals
        11.3.1 Taj Pharmaceuticals Company Details
        11.3.2 Company Business Overview
        11.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Taj Pharmaceuticals Amifostine Products Offered
        11.3.5 Taj Pharmaceuticals Recent Development
    11.4 Merro Pharmaceutical
        11.4.1 Merro Pharmaceutical Company Details
        11.4.2 Company Business Overview
        11.4.3 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Merro Pharmaceutical Amifostine Products Offered
        11.4.5 Merro Pharmaceutical Recent Development
    11.5 Luye Pharma
        11.5.1 Luye Pharma Company Details
        11.5.2 Company Business Overview
        11.5.3 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Luye Pharma Amifostine Products Offered
        11.5.5 Luye Pharma Recent Development
    11.6 Mingren Pharma
        11.6.1 Mingren Pharma Company Details
        11.6.2 Company Business Overview
        11.6.3 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Mingren Pharma Amifostine Products Offered
        11.6.5 Mingren Pharma Recent Development

12 Future Forecast
    12.1 Amifostine Market Forecast by Regions
        12.1.1 Global Amifostine Sales Forecast by Regions 2019-2025
        12.1.2 Global Amifostine Revenue Forecast by Regions 2019-2025
    12.2 Amifostine Market Forecast by Product
        12.2.1 Global Amifostine Sales Forecast by Product 2019-2025
        12.2.2 Global Amifostine Revenue Forecast by Product 2019-2025
    12.3 Amifostine Market Forecast by End User
    12.4 North America Amifostine Forecast
    12.5 Europe Amifostine Forecast
    12.6 Asia Pacific Amifostine Forecast
    12.7 Central & South America Amifostine Forecast
    12.8 Middle East and Africa Amifostine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Amifostine Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
Read More
List of Tables and Figures

    Figure Amifostine Product Picture
    Table Amifostine Market Segments
    Table Key Manufacturers Amifostine Covered
    Table Global Amifostine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
    Figure Global Amifostine Sales Market Share by Product 2014-2025
    Figure 400mg/Dose Product Picture
    Table Major Manufacturers of 400mg/Dose
    Figure 500mg/Dose Product Picture
    Table Major Manufacturers of 500mg/Dose
    Table Global Amifostine Market Size Growth Rate by End User 2019-2025 (K Units)
    Figure Head and Neck Cancer Adjuvant Therapy
    Figure Others
    Figure Amifostine Report Years Considered
    Figure Global Amifostine Market Size 2014-2025 (Million US$)
    Figure Global Amifostine Sales 2014-2025 (K Units)
    Table Global Amifostine Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Amifostine Sales by Regions 2014-2019 (K Units)
    Table Global Amifostine Sales Market Share by Regions 2014-2019
    Figure Global Amifostine Sales Market Share by Regions 2014-2019
    Figure 2018 Global Amifostine Sales Market Share by Regions
    Table Global Amifostine Revenue by Regions 2014-2019 (Million US$)
    Table Global Amifostine Revenue Market Share by Regions 2014-2019
    Figure Global Amifostine Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Amifostine Revenue Market Share by Regions
    Table Global Amifostine Sales by Manufacturers (2014-2019) (K Units)
    Table Global Amifostine Sales Share by Manufacturers (2014-2019)
    Figure Global Amifostine Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Amifostine Revenue by Manufacturers (2014-2019) (Million USD)
    Table Amifostine Revenue Share by Manufacturers (2014-2019)
    Figure Amifostine Value Share by Manufacturers in 2018
    Table Key Manufacturers Amifostine Price (2014-2019) (USD/Unit)
    Table Amifostine Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Amifostine Product Type
    Table Date of International Manufacturers Enter into Amifostine Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Amifostine Sales by Product (2014-2019) (K Units)
    Table Global Amifostine Sales Share by Product (2014-2019)
    Figure Global Amifostine Sales Market Share by Product (2014-2019)
    Figure Global Amifostine Sales Market Share by Product in 2018
    Table Global Amifostine Revenue by Product (2014-2019) (Million US$)
    Table Global Amifostine Revenue Share by Product (2014-2019)
    Figure Global Amifostine Revenue Market Share by Product (2014-2019)
    Figure Global Amifostine Revenue Market Share by Product in 2018
    Table Amifostine Price by Product 2014-2019 (USD/Unit)
    Table Global Amifostine Sales by End User (2014-2019) (K Units)
    Table Global Amifostine Sales Share by End User (2014-2019)
    Figure Global Sales Amifostine Market Share by End User (2014-2019)
    Figure Global Sales Amifostine Market Share by End User in 2018
    Figure North America Amifostine Sales Growth Rate 2014-2019 (K Units)
    Figure North America Amifostine Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Amifostine Sales by Countries (2014-2019) (K Units)
    Table North America Amifostine Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Amifostine Sales Market Share by Countries
    Table North America Amifostine Revenue by Countries (2014-2019) (Million US$)
    Table North America Amifostine Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Amifostine Revenue Market Share by Countries
    Figure United States Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure United States Amifostine Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Amifostine Sales by Product (2014-2019) (K Units)
    Table North America Amifostine Sales Market Share by Product (2014-2019)
    Figure 2018 North America Amifostine Market Share by Product
    Table North America Amifostine Sales by End User (2014-2019) (K Units)
    Table North America Amifostine Sales Market Share by End User (2014-2019)
    Figure 2018 North America Amifostine Market Share by End User
    Figure Europe Amifostine Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Amifostine Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Amifostine Sales by Countries (2014-2019) (K Units)
    Table Europe Amifostine Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Amifostine Sales Market Share by Countries
    Table Europe Amifostine Revenue by Countries (2014-2019) (Million US$)
    Table Europe Amifostine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Amifostine Revenue Market Share by Countries
    Figure Germany Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure France Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure UK Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Amifostine Sales by Product (2014-2019) (K Units)
    Table Europe Amifostine Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Amifostine Market Share by Product
    Table Europe Amifostine Sales by End User (2014-2019) (K Units)
    Table Europe Amifostine Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Amifostine Market Share by End User
    Figure Asia Pacific Amifostine Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Amifostine Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Amifostine Sales by Countries (2014-2019) (K Units)
    Table Asia Pacific Amifostine Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Amifostine Sales Market Share by Countries
    Table Asia Pacific Amifostine Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Amifostine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Amifostine Revenue Market Share by Countries
    Figure China Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure China Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure India Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Amifostine Sales by Product (2014-2019) (K Units)
    Table Asia Pacific Amifostine Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Amifostine Market Share by Product
    Table Asia Pacific Amifostine Sales by End User (2014-2019) (K Units)
    Table Asia Pacific Amifostine Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Amifostine Market Share by End User
    Figure Central & South America Amifostine Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Amifostine Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Amifostine Sales by Countries (2014-2019) (K Units)
    Table Central & South America Amifostine Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Amifostine Sales Market Share by Countries
    Table Central & South America Amifostine Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Amifostine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Amifostine Revenue Market Share by Countries
    Figure Brazil Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Amifostine Sales by Product (2014-2019) (K Units)
    Table Central & South America Amifostine Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Amifostine Market Share by Product
    Table Central & South America Amifostine Sales by End User (2014-2019) (K Units)
    Table Central & South America Amifostine Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Amifostine Market Share by End User
    Figure Middle East and Africa Amifostine Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Amifostine Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Amifostine Sales by Countries (2014-2019) (K Units)
    Table Middle East and Africa Amifostine Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Amifostine Sales Market Share by Countries
    Table Middle East and Africa Amifostine Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Amifostine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Amifostine Revenue Market Share by Countries
    Figure GCC Countries Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Amifostine Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Amifostine Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Amifostine Sales by Product (2014-2019) (K Units)
    Table Middle East and Africa Amifostine Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Amifostine Market Share by Product
    Table Middle East and Africa Amifostine Sales by End User (2014-2019) (K Units)
    Table Middle East and Africa Amifostine Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Amifostine Market Share by End User
    Table Clinigen Group Company Details
    Table Clinigen Group Amifostine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Clinigen Group Recent Development
    Table Sun Pharmaceutical Company Details
    Table Sun Pharmaceutical Amifostine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Sun Pharmaceutical Recent Development
    Table Taj Pharmaceuticals Company Details
    Table Taj Pharmaceuticals Amifostine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Taj Pharmaceuticals Recent Development
    Table Merro Pharmaceutical Company Details
    Table Merro Pharmaceutical Amifostine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Merro Pharmaceutical Recent Development
    Table Luye Pharma Company Details
    Table Luye Pharma Amifostine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Luye Pharma Recent Development
    Table Mingren Pharma Company Details
    Table Mingren Pharma Amifostine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Mingren Pharma Recent Development
    Table Global Amifostine Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Amifostine Sales Market Share Forecast by Regions 2019-2025
    Table Global Amifostine Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Amifostine Revenue Market Share Forecast by Regions 2019-2025
    Table Global Amifostine Sales Forecast by Product 2019-2025 (K Units)
    Table Global Amifostine Sales Market Share Forecast by Product 2019-2025
    Table Global Amifostine Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Amifostine Revenue Market Share Forecast by Product 2019-2025
    Table Global Amifostine Sales Forecast by End User 2019-2025 (K Units)
    Table Global Amifostine Sales Market Share Forecast by End User 2019-2025
    Figure North America Amifostine Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Amifostine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Amifostine Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Amifostine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Amifostine Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Amifostine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Amifostine Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Amifostine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Amifostine Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Amifostine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Amifostine Value Chain
    Table Amifostine Customers List
    Table Amifostine Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global Paclitaxel Injection Market Research Report 2021
Global Paclitaxel Injection Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-5J4435
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Lung Cancer Screening Software Market Size Status and Forecast 2021 2027
Global Lung Cancer Screening Software Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-36L4181
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Bone Allograft and Xenograft Market Research Report 2021
Global Bone Allograft and Xenograft Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-37P4169
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Enzymatic Debridement Market Research Report 2021
Global Enzymatic Debridement Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-38A4121
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0